Resistance mechanisms in clinical isolates of Candida albicans - Wikidata - wikimedia - TriplyDB

Resistance mechanisms in clinical isolates of Candida albicans

Resistance mechanisms in clinical isolates of Candida albicans

http://www.wikidata.org/entity/Q39652037

about

Pathogenesis and treatment of oral candidosis Coping with stress and the emergence of multidrug resistance in fungi Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis Xenobiotic efflux in bacteria and fungi: a genomics update Mechanisms and significance of fungicide resistance.Inhibition of efflux transporter-mediated fungicide resistance in Pyrenophora tritici-repentis by a derivative of 4'-hydroxyflavone and enhancement of fungicide activity.Genetic Basis of Antifungal Drug Resistance Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria.Efflux in fungi: la pièce de résistance Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.Oropharyngeal candidiasis in the era of antiretroviral therapy Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.The Evaluation of the virulence factors of clinical Candida isolates and the anti-biofilm activity of Elettaria cardamomum against multi-drug resistant Candida albicans.Emergence of azole-resistant Candida species in AIDS patients with oropharyngeal candidiasis in Iran.Drug-induced regulation of the MDR1 promoter in Candida albicans.Inactivation of sterol Delta5,6-desaturase attenuates virulence in Candida albicans Amino acid substitutions at the major insertion loop of Candida albicans sterol 14alpha-demethylase are involved in fluconazole resistance.UPC2 is universally essential for azole antifungal resistance in Candida albicans.Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans.Farnesol-induced apoptosis in Candida albicans is mediated by Cdr1-p extrusion and depletion of intracellular glutathione.Development and validation of an in vivo Candida albicans biofilm denture model.Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles.Characterization of plant-derived saponin natural products against Candida albicans.Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance.ROX1 and ERG regulation in Saccharomyces cerevisiae: implications for antifungal susceptibility Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants.Fungal biofilms and drug resistance.Structural basis for heterogeneous phenotype of ERG11 dependent Azole resistance in C.albicans clinical isolates Disruption of the transcriptional regulator Cas5 results in enhanced killing of Candida albicans by Fluconazole Multidrug-resistant transporter mdr1p-mediated uptake of a novel antifungal compound Antifungal drug resistance.Impact of recently emerged sterol 14{alpha}-demethylase (CYP51) variants of Mycosphaerella graminicola on azole fungicide sensitivity.Influence of culture media on biofilm formation by Candida species and response of sessile cells to antifungals and oxidative stress.Treatment of oral fungal infections using antimicrobial photodynamic therapy: a systematic review of currently available evidence.

P2860

Q24601191-CDD5F96E-ADE1-454A-AB57-E4D84F0FD757 Q27025256-39EB6876-D533-43F8-884A-067BFF4F8057 Q27315103-F421B6DC-925D-471E-8FFF-6A37E7CA5377 Q28469241-E6867001-CEF0-4A78-B5DB-E4B3C7508A86 Q28475655-91F27736-D2C5-4B53-8298-C9F389A31B56 Q28547078-D2649C70-8BA0-4C42-AE9A-5BE04E9DAED1 Q28818603-19FB30D9-1566-4CB2-8663-40E47372A2A9 Q28834633-689C4374-58AC-4684-8CD2-DF37E5A7BFBD Q30319644-82940022-3E3F-46B5-B2E2-2E64DEB3A84C Q30320212-D4B8E5C5-A65C-4558-9EC7-7696A86FA0D9 Q30434904-F8928D96-51F6-4C7F-BF60-E2E36AE56701 Q30452376-412A1C27-3BDA-4CA7-A799-B64F991DB504 Q33202199-3355719D-0B83-49D1-8386-4F6E30E35185 Q33474798-7556A866-CAAB-4454-8C84-DF498E32E69C Q33493582-02670205-FE09-4246-B730-2CE98D966A71 Q33746435-AB2FDED6-9084-4C69-A40A-A5542CACA681 Q33805788-528B8FB1-9D1A-4429-9111-56F1F29E38C4 Q33851327-9F93C3A5-2C80-48F2-9738-54FB686C5077 Q33851392-C2EF0EBF-FD2F-44CD-9579-06D6F9FF7EF6 Q33883805-173BE446-74A0-4C43-BF19-CE16B6F2D6D3 Q33935383-F82C2578-5D1B-43F2-9875-76A3764A8E58 Q33940714-6CFFD6DF-688D-4CA6-8082-7F1A9D06B974 Q34057076-0D2D2001-9DCD-4D14-8ED2-1C1B4C9F952A Q34088663-3F5E09D5-68E8-4CBE-8D90-645BD13F548B Q34113632-B86D7476-7C50-43E7-BF43-B5EF4ED7A801 Q34119405-0A69478F-7707-4FDC-8B28-54BE3C2D5DE4 Q34141180-1569E97D-DE6F-4C2A-ABE3-7966F1EB4BF5 Q34248026-89960AFD-6AFB-41CA-959B-AA6F2A39AA0D Q34290134-FD512B4A-C5A4-4079-AE2D-3C2AC336489C Q34352293-AD4D91B9-282F-4E36-9E2B-5402E6C0B145 Q34420719-4A99A8E3-708A-4283-9D1B-4FB154D2927F Q34510712-6774CEEA-3A7B-4488-974D-6ED450A8619E Q34540389-A7FC7235-9844-41CB-87CA-CA78ABE7B2EC Q34543717-C30587E2-F3A8-47B6-A62C-00611A8D8201 Q34596791-5D469607-98B0-42E0-98A5-81F42E985299 Q34991073-9A508C06-F6C5-45F7-8E51-04DAACEEA1FA Q35040008-5FBA0F5F-F475-469E-9A69-E1EBBDC98A69 Q35080726-7997D28D-15F9-4171-A215-FF88D772C9F9 Q35091118-0C86FC56-FDC5-4A89-8C45-4B3F08889366 Q35136032-C5F5C89D-F760-4F77-AF76-FFC91A0986F1

P2860

Resistance mechanisms in clinical isolates of Candida albicans

http://www.wikidata.org/entity/Q39652037

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Resistance mechanisms in clinical isolates of Candida albicans

@en

Resistance mechanisms in clinical isolates of Candida albicans.

@nl

type

label

Resistance mechanisms in clinical isolates of Candida albicans

@en

Resistance mechanisms in clinical isolates of Candida albicans.

@nl

prefLabel

Resistance mechanisms in clinical isolates of Candida albicans

@en

Resistance mechanisms in clinical isolates of Candida albicans.

@nl

P1433

Q39652037-B55C142D-865C-4EC8-A925-8AF984E7E847

P1476

Q39652037-1AF31870-CDC2-4D0D-A676-1CB72814FA32

P2093

Q39652037-99E32C24-7753-45C2-8AE2-46FE52B40F87

Q39652037-A945F475-22C9-4B33-9461-912004E9F1C4

Q39652037-B4420BAD-F2DD-43F7-A8C0-F305A87782A6

Q39652037-DA0EE4B2-9466-4F1D-AC44-B7F4C75DA7B8

Q39652037-E55A8FBB-DCCD-4054-B100-18EA02FEEEBD

P2860

Q39652037-03320BC3-3512-4C0E-8422-36BBDFC4054F

Q39652037-0D38A539-2226-45F4-8A84-136F3F46A1B1

Q39652037-30F466FF-4CEA-4637-886E-BCF7F9F8A44E

Q39652037-35364215-DA24-4CC2-B726-A7BA59C02727

Q39652037-444B42B9-BE49-4569-AC4D-18D77DA84BD8

Q39652037-53883E25-A868-427C-8CEE-206622BC6F54

Q39652037-5E641C3C-F0B7-4032-A823-10FE2A9AB06C

Q39652037-608EE8C9-B17D-4881-BF90-3613622D710D

Q39652037-6AC448E7-7B91-483F-AC29-ED6F29428632

Q39652037-70DC5A28-E933-43DD-8C37-B5E29E082B24

P304

Q39652037-5F534EB9-C4E9-4D87-A9FD-3162C0C52039

P31

Q39652037-F9C84C28-602F-4747-8138-7C487F509B28

P356

Q39652037-ACDD67AC-3C74-4679-BC7E-432E66A74DF4

P407

Q39652037-E6F891E0-671A-4A74-AA6F-4E17E35AD99E

P433

Q39652037-69999F17-2B82-4C91-8AB0-6F2E1027B9B8

P478

Q39652037-DD7D6D08-5045-4543-8BCA-31EAD92DDB7B

P577

Q39652037-53969F93-346E-448F-B377-6904834325C9

P698

Q39652037-543FEF59-02B4-4B8B-8B64-52C1C81ED76A

P932

Q39652037-215899D0-10BA-41B4-8F70-7027FE9D4EB2

P356

AAC.46.6.1704-1713.2002

P1433

Antimicrobial Agents and Chemotherapy

P1476

Resistance mechanisms in clinical isolates of Candida albicans

@en

P2093

David A Stevens

http://www.w3.org/2001/XMLSchema#string

Francis Dy

http://www.w3.org/2001/XMLSchema#string

Laurence F Mirels

http://www.w3.org/2001/XMLSchema#string

Scott Holleman

http://www.w3.org/2001/XMLSchema#string

Theodore C White

http://www.w3.org/2001/XMLSchema#string

P2860

A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli

Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals

A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole.

A fourth gene from the Candida albicans CDR family of ABC transporters.

Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate.

Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.

Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.

Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene

P304

1704-1713

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.46.6.1704-1713.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12019079

http://www.w3.org/2001/XMLSchema#string

P932

127245

http://www.w3.org/2001/XMLSchema#string